IMPACT BIOMEDICAL INC.
For the period ended Dec 31, 2025. Filed Mar 11, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 11, 2026
IBO$4.33+5.6%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets
As of December 31,
| 2025 | 2024 | |
|---|---|---|
| ASSETS | ||
| Current assets: | ||
| Cash and cash equivalents | $3,000 | $1,999,000 |
| Accounts receivable | 5,000 | - |
| Inventory | 63,000 | - |
| Current portion of notes receivable | 198,000 | 184,000 |
| Prepaid expenses and other current assets | 142,000 | 265,000 |
| Total current assets | 411,000 | 2,448,000 |
| Property, plant and equipment, net | - | 17,000 |
| Notes receivable | - | 17,000 |
| Other intangible assets, net | 16,994,000 | 17,808,000 |
| Total assets | $17,405,000 | $20,290,000 |
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||
| Current liabilities: | ||
| Accounts payable | $347,000 | $314,000 |
| Accrued expenses | 194,000 | 194,000 |
| Due to related party | 621,000 | 399,000 |
| Note payable, related party | - | 8,878,000 |
| Total current liabilities | 1,162,000 | 9,785,000 |
| Deferred tax liability, net | 688,000 | 3,268,000 |
| Total liabilities | 1,850,000 | 13,053,000 |
| Commitments and contingencies (Note 12) | - | - |
| Stockholders’ equity | ||
| Preferred stock, $0.001 par value; 100,000,000 shares authorized, zero shares issued and outstanding (60,496,041 on December 31, 2024); Liquidation value $0.001 per share, zero aggregate. $60,496,041,000 on December 31, 2024). | - | 60,000 |
| Common stock, $0.001 par value; 4,000,000,000 shares authorized, 104,621,231 shares issued and outstanding (11,503,955 on December 31, 2024) | 105,000 | 11,000 |
| Additional paid-in capital | 62,011,000 | 41,857,000 |
| Accumulated deficit | (49,507,000) | (37,669,000) |
| Total stockholders’ equity of the Company | 12,609,000 | 4,259,000 |
| Non-controlling interest in subsidiaries | 2,946,000 | 2,978,000 |
| Total stockholders’ equity | 15,555,000 | 7,237,000 |
| Total liabilities and stockholders’ equity | $17,405,000 | $20,290,000 |
**I
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.